NuCana (NCNA) Prices 15.56M ADS Offering at $4.50/ADS

Go back to NuCana (NCNA) Prices 15.56M ADS Offering at $4.50/ADS

After-Hours Movers 9/16: (MLHR) (SCS) (MRNA) Higher; (SBBP) (NCNA) (FSLR) Lower (more...)

September 16, 2020 5:35 PM EDT

After-Hours Movers

Herman Miller (NASDAQ: MLHR) 15.2% HIGHER; reported Q1 EPS of $1.24, $0.98 better than the analyst estimate of $0.26. Revenue for the quarter came in at $626.8 million versus the consensus estimate of $524.83 million.

Strongbridge Biopharma plc, (Nasdaq: SBBP)... More

NuCana (NCNA) Announces Proposed Public Offering of ADSs

September 16, 2020 4:02 PM EDT

NuCana plc, (Nasdaq: NCNA) a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer, announced today that it has commenced an underwritten public offering of its American Depositary Shares (ADSs). Each ADS represents one ordinary share of NuCana. In addition,... More